Hematology

Filter

Brain And Spinal Cord Relapse Risk Identified in Leukaemia

March 2026

A large retrospective study identified risk factors for CNS relapse after transplant in adults with acute lymphoblastic leukaemia, highlighting elevated risk in Philadelphia chromosome positive disease.

EMJ

Virtual Blood Could Be the Key to More Effective Treatments for Blood Cancers

DEVELOPMENT of treatments for leukaemia and lymphoma could be aided by a new computer model that simulates the development of blood cells…

EMJ

New Treatment Option for CLL Patients with Poorest Prognosis

Patients with a particularly difficult-to-treat form of chronic lymphocytic leukaemia have gained access to a new treatment option in the US…

EMJ

IMBRUVICA™ (Ibrutinib) Now Approved in the u.s. For Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy

HORSHAM, PA, February 12, 2014 – Janssen Biotech, Inc. [“Janssen”] today announced the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™…

Loading posts...

« Previous 1 … 45 46 47